Ramin Khoramnia, MD, FEBO, Technische Universität Dresden, Germany
Nirmal Jayabalan, PhD, Birla Institute of Technology and Science, India
BMC Ophthalmology is calling for submissions to our Collection on Advances in ocular drug delivery.
This Collection seeks to highlight research on the latest technology in drug delivery in Ophthalmology.
Ramin Khoramnia, MD, FEBO, Technische Universität Dresden, Germany
Prof Dr Ramin Khoramnia is chairman, University Professor, and high-volume surgeon at the Department of Ophthalmology of the University Clinic Carl Gustav Carus at the TU Dresden. His research is mainly focused on biomaterials, drugs, and intraocular lens optics. Prof Dr Khoramnia is a key opinion leader (KOL) and well-known expert in the field of presbyopia treatment, cataract and refractive surgery (including different kinds of premium intraocular lenses and surgical devices) and retinal diseases (especially intravitreal medication for macular diseases).
Prof Dr Khoramnia was a scholar of the Konrad Adenauer Foundation. He has received the European Board of Ophthalmology Certification (Fellow of the European Board of Ophthalmology – F.E.B.O.) in 2013 after participation at the European Board of Ophthalmology Diploma (EBOD) Examination as the second best participant amongst more than 440 participants from 24 European countries.
His clinical experience and research interests include presbyopia treatment, cataract surgery (biomaterials, intraocular lenses, optics, and ophthalmic viscoelastic devices), refractive laser technology and surgery, diagnostic tools as well as retinal (especially intravitreal medications for macular diseases), corneal and uveitic diseases.
Prof Dr Khoramnia serves as principal investigator and co-investigator on multiple clinical trials. He has written numerous book chapters and has published more than 320 papers in peer-reviewed journals, including publications such as in the prestigious New England Journal of Medicine, Lancet and American Journal of Ophthalmology, among others. He is an Associate Editor of the American Journal of Ophthalmology CR and Journal of Medical Case Reports, an Editorial Board member of BMC Ophthalmology, Scientific reports, Frontiers in Medicine, Ophthalmologie and Klinische Monatsblaetter Augenheilkunde, a guest editor of the journals Diagnostics and Journal of Ophthalmology and he also serves as a reviewer for many peer reviewed journals.
The Achievement Award of the American Academy of Ophthalmology (AAO), the ASCRS Foundation Resident Excellence Award, the Runner-up Video Award of the American Society of Cataract and Refractive Surgeons (ASCRS), the second Poster Award of the European Society of Cataract and Refractive Surgeons (ESCRS), the JCRS Rosen Award of the Journal of Cataract and Refractive Surgery as well as the Best Poster Award of the American Academy of Ophthalmology (AAO) are among the many awards for his scientific work.
Nirmal Jayabalan, PhD, Birla Institute of Technology and Science, India
Prof Nirmal Jayabalan is an Associate Professor in the Department of Pharmacy at BITS Pilani, Hyderabad campus, where he is the principal investigator at the Translational Pharmaceutics Research Laboratory. He earned his PhD from the All India Institute of Medical Sciences (AIIMS), New Delhi, followed by postdoctoral training at the Oakland University William Beaumont School of Medicine, Michigan, USA, and Nanyang Technological University, Singapore.
Prof Nirmal has been recognized with prestigious awards, including the Research Scholars Award (AFUD) from the Urology Care Foundation, USA, and the Best Research Fellow award from the Ophthalmic Research Association, AIIMS, New Delhi. His research expertise lies in ocular drug delivery, ocular pharmacokinetics, drug transporter, and drug repurposing. His research group focuses on the development of ophthalmic formulations targeting both anterior and posterior segments of the eye. The team also evaluates the preclinical safety, efficacy, and pharmacokinetics of these formulations, with an emphasis on optimizing drug delivery using minimally invasive approaches. Additionally, his work integrates artificial intelligence to predict ocular toxicity, advancing precision medicine in ophthalmology.
Prof Nirmal’s scholarly contributions include over 68 peer-reviewed publications, 121 conference presentations, 10 patents, and 15 book chapters. Currently, he supervises one postdoctoral fellow and 16 Ph.D. scholars, guiding them in advancing research in ocular pharmacology and therapeutics.
BMC Ophthalmology is calling for submissions to our Collection on Advances in ocular drug delivery.
Delivering therapeutic agents to the eye presents unique challenges, such as overcoming the eye's protective barriers , including the blood-aqueous and blood-retinal barriers, and ensuring precise targeting to treat various ocular conditions effectively.
Recent advancements have led to the development of novel drug delivery systems, including nanoparticles and sustained-release implants. These innovations are designed to target specific tissues within the eye, improving drug bioavailability and reducing the frequency of administration. Therefore, providing more effective and less invasive solutions for managing ocular diseases.
This Collection seeks to highlight research on the latest techniques and advances in ocular drug delivery. We welcome research articles on topics including, but not limited to:
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Image credit: © NANOCLUSTERING / Science Photo Library
There are currently no articles in this collection.
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Advances in ocular drug delivery" from the dropdown menu.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.